Literature DB >> 17918923

From docking false-positive to active anti-HIV agent.

Gabriela Barreiro1, Joseph T Kim, Cristiano R W Guimarães, Christopher M Bailey, Robert A Domaoal, Ligong Wang, Karen S Anderson, William L Jorgensen.   

Abstract

Virtual screening of the Maybridge library of ca. 70 000 compounds was performed using a similarity filter, docking, and molecular mechanics-generalized Born/surface area postprocessing to seek potential non-nucleoside inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (NNRTIs). Although known NNRTIs were retrieved well, purchase and assaying of representative, top-scoring compounds from the library failed to yield any active anti-HIV agents. However, the highest-ranked library compound, oxadiazole 1, was pursued as a potential "near-miss" with the BOMB program to seek constructive modifications. Subsequent synthesis and assaying of several polychloro-analogs did yield anti-HIV agents with EC50 values as low as 310 nM. The study demonstrates that it is possible to learn from a formally unsuccessful virtual-screening exercise and, with the aid of computational analyses, to efficiently evolve a false positive into a true active.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17918923      PMCID: PMC2575345          DOI: 10.1021/jm070683u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

Review 1.  Molecular complexity and its impact on the probability of finding leads for drug discovery.

Authors:  M M Hann; A R Leach; G Harper
Journal:  J Chem Inf Comput Sci       Date:  2001 May-Jun

2.  Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.

Authors:  Robert C Rizzo; Marina Udier-Blagović; De-Ping Wang; Edward K Watkins; Marilyn B Kroeger Smith; Richard H Smith; Julian Tirado-Rives; William L Jorgensen
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

3.  FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Joseph T Kim; Andrew D Hamilton; Christopher M Bailey; Robert A Domaoal; Robert A Domoal; Ligong Wang; Karen S Anderson; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2006-12-06       Impact factor: 15.419

4.  Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors.

Authors:  Maria Letizia Barreca; Laura De Luca; Nunzio Iraci; Angela Rao; Stefania Ferro; Giovanni Maga; Alba Chimirri
Journal:  J Chem Inf Model       Date:  2007-02-03       Impact factor: 4.956

Review 5.  Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.

Authors:  Andrew R Leach; Brian K Shoichet; Catherine E Peishoff
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

6.  Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.

Authors:  Gabriela Barreiro; Cristiano R W Guimarães; Ivan Tubert-Brohman; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Inf Model       Date:  2007-10-20       Impact factor: 4.956

7.  Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase.

Authors:  Martha De La Rosa; Hong Woo Kim; Esmir Gunic; Cheryl Jenket; Uyen Boyle; Yung-Hyo Koh; Ilia Korboukh; Matthew Allan; Weijian Zhang; Huanming Chen; Wen Xu; Shahul Nilar; Nanhua Yao; Robert Hamatake; Stanley A Lang; Zhi Hong; Zhijun Zhang; Jean-Luc Girardet
Journal:  Bioorg Med Chem Lett       Date:  2006-06-27       Impact factor: 2.823

8.  Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Vinay V Thakur; Joseph T Kim; Andrew D Hamilton; Christopher M Bailey; Robert A Domaoal; Ligong Wang; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

9.  Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues.

Authors:  D W Ludovici; B L De Corte; M J Kukla; H Ye; C Y Ho; M A Lichtenstein; R W Kavash; K Andries; M P de Béthune; H Azijn; R Pauwels; P J Lewi; J Heeres; L M Koymans; M R de Jonge; K J Van Aken; F F Daeyaert; K Das; E Arnold; P A Janssen
Journal:  Bioorg Med Chem Lett       Date:  2001-09-03       Impact factor: 2.823

10.  Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent.

Authors:  Adrian S Ray; Zhenjun Yang; Chung K Chu; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

View more
  22 in total

1.  Effects of Water Placement on Predictions of Binding Affinities for p38α MAP Kinase Inhibitors.

Authors:  James Luccarelli; Julien Michel; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Theory Comput       Date:  2010-01-01       Impact factor: 6.006

Review 2.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.

Authors:  Gabriela Barreiro; Cristiano R W Guimarães; Ivan Tubert-Brohman; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Inf Model       Date:  2007-10-20       Impact factor: 4.956

4.  Grid-based molecular footprint comparison method for docking and de novo design: application to HIVgp41.

Authors:  Trent E Balius; William J Allen; Sudipto Mukherjee; Robert C Rizzo
Journal:  J Comput Chem       Date:  2013-02-22       Impact factor: 3.376

5.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

6.  Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.

Authors:  William J Allen; Brian C Fochtman; Trent E Balius; Robert C Rizzo
Journal:  J Comput Chem       Date:  2017-09-22       Impact factor: 3.376

7.  Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization.

Authors:  Julien Michel; Julian Tirado-Rives; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

8.  C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.

Authors:  Roger Hunter; Yassir Younis; Clare I Muhanji; Tanith-Lea Curtin; Kevin J Naidoo; Melissa Petersen; Christopher M Bailey; Aravind Basavapathruni; Karen S Anderson
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

9.  Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Authors:  Adam J T Smith; Xiyun Zhang; Andrew G Leach; K N Houk
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

10.  Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations.

Authors:  Jacob G Zeevaart; Ligong Wang; Vinay V Thakur; Cheryl S Leung; Julian Tirado-Rives; Christopher M Bailey; Robert A Domaoal; Karen S Anderson; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2008-06-28       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.